Saar Gill, MD, PhD
Dr. Saar Gill is an Associate Professor of Medicine in the Division of Hematology-Oncology at the University of Pennsylvania. He trained in clinical hematology in his native Australia, followed by a postdoctoral fellowship at Stanford University. Dr. Gill co-founded Carisma Therapeutics with his first graduate student, Michael Klichinsky, and recently co-founded Interius Biotherapeutics.`
Since 2011, he has been working on developing genetically engineered immune cells for the treatment of cancer. Dr. Gill is a physician-scientist who places a strong emphasis on translational research, and concepts developed in his laboratory have already led to several clinical trials for the treatment of hematologic malignancies. The Gill Lab focuses on pushing the frontier of CAR therapies leading to several paradigm-shifting innovations including CART123 for acute myeloid leukemia, CAR macrophages for solid tumors, and pairing CART33 treatment with CRISPR-edited CD33-deficient bone marrow transplants. Each of these technologies is currently being pursued in early phase clinical trials, and promises to alter the landscape of cancer immunotherapy and pave the way for further innovation.
DatesNovember 14, 2023
LocationGladstone Mahley Auditorium & Online
AudienceGladstone and UCSF
The Gladstone-UCSF Institute of Genomic Immunology Seminar Series showcases speakers at the intersection of genomic technology and immunology research with an aim to engineer the human immune system for therapeutic benefit. Speakers span technology development, synthetic biology, bioengineering, and the development and clinical application of immunotherapy. These talks are open to the Gladstone and UCSF communities.
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.